Top news from MedWatch this week
Monday
William Demant Invest report reveals GN Group stake
Adolescent patients’ eczema improved in Leo Pharma’s late-stage testing
Tuesday
Cryptic message about future of Leo Pharma’s R&D chief left unexplained
Coloplast updates inflatable penile implant production after recalls
Wednesday
New hearing company 14 years in the making – ”We expect to rise to the top”
Another UK authority looking into Novo Nordisk’s marketing violation
Thursday
Patient group did not disclose Novo Nordisk ties in obesity treatment campaign
Novo Nordisk enters multimillion-dollar partnership to slow insulin resistance
Ambu ruled out raising capital in August – now it’s ”due diligence”
Friday
Novo Nordisk denies Danish stealth marketing, admits to carrying responsibility for grant usage
Less than one in five Novo Nordisk execs is a woman – chairman expects change over time
